Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) Network
The UCSF Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) Network at San Francisco General Hospital conducts clinical trials evaluating the optimal management of HIV and associated complications, strategies for HIV eradication, and treatment of viral hepatitis and tuberculosis. As part of the NIH-funded multicenter ACTG clinical trials network, this clinical trials unit has access to a broad menu of cutting edge studies and conducts research addressing health issues of key importance to the San Francisco population.
Areas of Current Focus
Innovative antiretroviral approaches to minimize long term toxicity for HIV treatment naïve and treatment experienced patients
Strategies to control HIV related inflammation, reduce the HIV reservoir and ultimately eradicate HIV.
Development of shorter, more potent and potentially curative HBV therapies in both HIV-HBV coinfected and HBV monoinfected patients.
Improved tuberculosis diagnosis and treatment of active and latent tuberculosis infection
Treatment and prevention of emerging infectious diseases such as MPOX and COVID-19.
For more information on currently enrolling studies, contact us via phone at (415) 535-9495 or email: [email protected].
For more information on the ACTG clinical trials network, please visit http://www.actgnetwork.org.